Pineda’s Suspension Is a Serious Blow to the Twins
After frittering away what was once an 11 1/2-game lead over the Indians, the Twins have reestablished firm control of the AL Central race, but this weekend, their hopes to play deep into October took a hit when Michael Pineda was suspended for 60 games for violating MLB’s Joint Drug Prevention and Treatment Program. Pineda tested positive for hydrochlorothiazide, a diuretic on the league’s banned substances list, and while his suspension was reduced from the standard 80 games upon appeal, he won’t be available for the playoffs, making this one of the most impactful recent Joint Drug suspensions.
Pineda’s suspension was announced amid a three-game series between the division rivals. On Friday night, he held the Indians to one run over six innings while striking out a season-high 10; he left the game carrying a 2-1 lead, but the Indians tied the game in the eighth and won 6-2 in 11 innings. The next day, MLB announced the suspension, and while a fired-up Twins team rallied late to win 5-3 and cut the team’s magic number to clinch the division to 14, they lost the rubber match on Sunday, 5-2.
In a statement released by the Major League Baseball Players Association, 30-year-old Pineda said in part:
“I mistakenly took a medication that was given to me by a close acquaintance, who obtained it over-the-counter and assured me it would safely help me manage my weight. I ingested a few of these pills without the consent of the Twins’ training staff. Testing revealed trace elements of a substance called Hydrochlorothiazide, which is a banned diuretic under baseball’s testing program.”
Hydrochlorothiazide is a medication used to treat high blood pressure and fluid retention (edema) by producing more urine, which helps the body get rid of excess sodium and water. It’s on the list of banned substances because it is often abused as a masking agent, which helps to to conceal the use of anabolic steroids by reducing their concentration in urine due to the increase in volume. Read the rest of this entry »
Jay Jaffe